Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free iron ions refer to iron atoms present in biological systems in their ionic forms (most commonly ferrous, Fe²⁺, and ferric, Fe³⁺) that are not tightly bound to proteins or cofactors. While transition metal ions such as iron are essential for life, especially as enzymatic cofactors and in oxygen transport, unshielded iron ions can catalyze the production of reactive oxygen species, leading to oxidative stress, cell damage, and disease. Iron is tightly regulated in cells to minimize the amount of labile or free iron, and excess free iron is stored in ferritin or bound by transferrin to prevent toxicity. Therapeutic interventions aim to reduce free iron using chelators in cases of iron overload. “Free iron ions” is not a defined molecular structure or a protein target but a chemical species whose quantity and reactivity are central to health, disease, and treatment strategies related to iron homeostasis.
Chelation of free iron ions (drugs bind iron and promote its excretion or sequestration, reducing toxicity and oxidative damage)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free iron ion.